Reditus Laboratories

10/31/2022

We all want children to have fun on Halloween but we also want them to be safe. Safe Kids Worldwide recommends that trick-or-treaters wear costumes that fit well and that trick-or-treaters choose face paint over masks to reduce the risk of falls. Trick-or-treaters also should carry glow sticks or flashlights, use reflective tape or stickers on costumes and bags and wear light colors so they can be seen by drivers. Parents or guardians should join children under 12 for trick-or-treating. And drivers are reminded to slow down and be alert because trick-or-treaters may dart into the street.

10/27/2022

Reditus Laboratories is a full-service, CAP-accredited reference lab located in Central Illinois. We offer histology, cytogenetics, cytology, hematology, chemistry, microbiology, molecular diagnostics, PCR assays and upcoming next-generation sequencing for hospitals and other medical providers. See you at the Illinois Critical Access Hospital Network Annual Conference on Nov. 10 at the I-Hotel and Conference Center in Champaign. Email b.zowin@redituslabs.com for more information about Reditus.

10/26/2022

Reditus Laboratories offers both multiplex PCR-based urinary tract infection (UTI) analysis and traditional urine culture to identify pathogens. Learn more herehttps://precision-healthsolutions.com/wp-content/uploads/2021/11/Molecular-vs.-Culture-UTI-Study.pdf Check out the tests we offer by visiting our booth at the Illinois Critical Access Hospital Network (ICAHN) Annual Conference on Nov. 10 at the I-Hotel and Conference Center in Champaign or by emailing b.zowin@redituslabs.com.

10/24/2022

Reditus Laboratories will be adding to its extensive menu of tests in the coming months, adding PCR testing of stool samples for viruses and bacteria, and comprehensive genomic profiling of solid tumors using next-generation sequencing. Stay tuned for more information as we continue to grow.

10/21/2022

, which is part of , reminds women to schedule their mammogram, which frequently can detect breast cancer when it is at an early, treatable stage. Baseline mammograms are offered beginning at age 35 unless family history indicates sooner. Women age 40 and older are recommended to receive yearly preventative mammograms.

10/19/2022

10/17/2022

Hillary Cerven enjoys working at Reditus Laboratories because they share the same vision: providing the best possible testing for patients. Cerven is Reditus' technical supervisor for microbiology and molecular and is among the medical professionals who ensure that Reditus testing remains accurate and timely. For more information, check out https://www.redituslabs.com/

10/14/2022

In testing for cervical cancer, Reditus Laboratories' two cytotechnologists have a combined experience of 91 years. They strive for accuracy and a quicker turnaround time than other labs. That means accurate results get to the doctor and patient sooner. Medical providers interested in Reditus performing gynecological cytology for them may contact Colton Moore, our vice president of sales, at c.moore@redituslabs.com.

10/06/2022

Representatives of Reditus Laboratories delivered a presentation on UroVysion, a bladder cancer test that is more sensitive than other tests for the disease, at Midwest Urological Group recently. Speaking for Reditus were Karen Simpson, general supervisor of cytogenetics; Michelle Anderson, director of operations; and Mark Potts, cytogenetics and digital pathology technologist. Dr. Joseph Banno, of Midwest Urological Group, said the group wants to expand its use of UroVysion. "As diagnostics have become more sophisticated, we're looking at the molecular makeup of the cell, which is giving us more definitive information on the diagnosis and treatment of the cancer," Banno said. In the first photo, talking after the presentation, are, from left to right, Josh Auer, advanced practice registered nurse; Banno; Laura Wilson Brown, physician assistant, certified; Anderson and Simpson. In the second photo, Potts, Anderson and Simpson listen during the meeting. Urologists interested in Reditus performing UroVysion for them may contact Simpson at k.simpson@redituslabs.com.

10/04/2022

Worried about COVID-19 as the school year progresses and as the BA.5 variant continues to make people ill? Reditus Laboratories continues to offer COVID-19 testing for schools and colleges. For more information, email w.rossi@redituslabs.com.

09/27/2022

Reditus Laboratories offers a variety of lab testing - including PCR testing of wound specimens - for private medical practices, hospitals, corporations, long-term care facilities and other labs. Reditus is becoming a full-service lab with the latest technology and competitive turnaround times. Anyone interested in testing may email n.wamsley@redituslabs.com.

09/23/2022

We are adding nucleic acid testing for sexually transmitted infections. Reditus testing offers longer stability of specimens, higher sensitivity of infection and faster turnaround time for results. Medical providers may email c.moore@redituslabs.com.